Daily Archive: March 31, 2012

1

BIO CEO: IPR System Threatens Medical Innovation

BIO CEO: IPR System Threatens Medical Innovation In an article published earlier this fall on Medium, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood urges Congress to modify the inter partes review (IPR)...